medigraphic.com
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán

2026, Number 2

<< Back Next >>

Rev Biomed 2026; 37 (2)

Biotic components as an alternative for the improvement of dermatological diseases. Descriptive review

Jan-Roblero J, Loaeza-Cruz BS, Aguilar-Fortanell P, Hernández-Santos LF

Language: Spanish
References: 58
Page: 63-75
PDF size: 424.32 Kb.


ABSTRACT

The skin is the largest and most extensive organ in the human body and forms the boundary between the individual and their environment. The skin’s microbiota is closely linked to it and plays various roles in dermatological health. Skin dysbiosis, characterized by changes in the diversity and quantity of microorganisms, leads to skin diseases. Over the past decade, there has been a significant increase in the number of patients presenting with skin disorders resulting from dysbiosis. Furthermore, it has been suggested that biotic components can restore skin dysbiosis. The objective of this review is therefore to analyze the effect of such components, including probiotics, prebiotics, symbiotics, and postbiotics, in counteracting skin dysbiosis and restoring the skin microbiota. Studies published in PubMed, SciELO and Google Scholar between 2020 and 2025 were included in the search, using the keywords “biotic components” and “dermatological diseases” in English or Spanish. This descriptive review examined biotic components incorporated into dermatological products to treat conditions such as acne, atopic dermatitis, seborrheic dermatitis, rosacea, psoriasis and skin cancer. In conclusion, dermatological products fortified with probiotics, prebiotics and/or postbiotics offer therapeutic potential for treating skin conditions and improving skin aesthetics.


REFERENCES

  1. Potbhare R, RaviKumar A, Munukka E, Lahti L, AshmaR. Skin microbiota diversity among genetically unrelatedindividuals of Indian origin. Peer J. 2022 Mar 16; 10:e13075. doi: 10.7717/peerj.13075

  2. Timm CM, Loomis K, Stone W, Mehoke T, BrensingerB, Pelletier DA, et al. Isolation and characterization ofdiverse microbial representatives from the human skinmicrobiome. Microbiome. 2020 Apr 22; 8(1): 58. doi:10.1186/s40168-020-00831-y

  3. Pereira MS, Redanz S, Kriegel MA. Skin deep: therole of the microbiota in cutaneous autoimmunity. JInvest Dermatol. 2022 Mar; 142(3 Pt B): 834-40. doi:10.1016/j.jid.2021.12.005

  4. Medina-Castillo DE, Pérez-López JA, Aguilar-MedinaDA, De la Cruz-Medina R. Microbioma, acné yprobióticos orales. Dermatol Rev Mex. 2024; 68(1): 51-63. doi: 10.24245/drm/bmu.v68i1.9475

  5. Ito Y, Amagai M. Dissecting skin microbiota andmicroenvironment for the development of therapeuticstrategies. Curr Opin Microbiol. 2023 Aug; 74: 102311.doi:10.1016/j.mib.2023.102311

  6. Cancino Díaz JC, Cancino Díaz ME, RodríguezMartínez S, Castañeda Sánchez JI, editores.Staphylococcus epidermidis: desde la inocuidadhasta la patogenia. 1.ª ed. Ciudad de México:Universidad Autónoma Metropolitana, 2024. Pp. 380ISBN: 9786072831100. Disponible en: https://repositorio.xoc.uam.mx/jspui/handle/123456789/43962

  7. Skowron K, Bauza-Kaszewska J, Kraszewska Z,Wiktorczyk-Kapischke N, Grudlewska-Buda K,Kwiecińska-Piróg J, et al. Human skin sicrobiome:impact of intrinsic and extrinsic factors on skinmicrobiota. Microorganisms. 2021 Mar 5; 9(3):543. doi:10.3390/microorganisms9030543

  8. Celorio-Murillo WJ, Benavides-Tulcán E. Probióticosy prebióticos: beneficios en dermatología. Rev ChilDermatol. 2021. 31 (1): 6-11. doi: 10.31879/rcderm.v37i1.364

  9. Pérez-Chabela ML, Yenizey M, Soriano-Santos J, Pérez-Hernández MA. Los probióticos y sus metabolitos enla acuicultura. Una revisión. Hidrobiológica. 2020oct 1; 30(1):93–105. doi: 10.24275/uam/izt/dcbs/hidro/2020v30n1/perez

  10. Gurunathan S, Thangaraj P, Kim JH. Postbiotics:functional food materials and therapeutic agents forcancer, diabetes, and inflammatory diseases. Foods.2023 Dec 26; 13(1):89. doi: 10.3390/foods13010089

  11. Vinderola G, Sanders ME, Cunningham M, Hill C.Frequently asked questions about the ISAPP postbioticdefinition. Front Microbiol. 2024 Jan 10; 14:1324565.doi: 10.3389/fmicb.2023.1324565

  12. Podwojniak A, Tan IJ, Sauer J, Neubauer Z, RothenbergH, Ghani H, et al. Acne and the cutaneous microbiome:a systematic review of mechanisms and implications fortreatments. J Eur Acad Dermatol Venereol. 2025 Apr;39(4): 793-805. doi: 10.1111/jdv.20332

  13. Sánchez-Pellicer P, Navarro-Moratalla L, Núñez-Delegido E, Ruzafa-Costas B, Agüera-Santos J, Navarro-López V. Acne, microbiome, and probiotics: The gut–skin axis. Microorganisms. 2022 Jun 27; 10(7): 1303.doi: 10.3390/microorganisms10071303

  14. Han HS, Shin SH, Choi BY, Koo N, Lim S, Son D, et al.A split face study on the effect of an anti-acne productcontaining fermentation products of Enterococcusfaecalis CBT SL-5 on skin microbiome modification andacne improvement. J Microbiol. 2022 May; 60(5): 488-495. doi: 10.1007/s12275-022-1520-6

  15. Podrini C, Schramm L, Marianantoni G, ApolinarskaJ, McGuckin C, Forraz N, et al. Topical administration of Lactiplantibacillus plantarum (SkinDuoTM) serumimproves anti-acne properties. Microorganisms. 2023Feb 7; 11(2):417. doi: 10.3390/microorganisms11020417

  16. Pachacama-López AF, Tapia-Portilla MF, Moreno-Piedrahíta Hernández F, Palacios-Álvarez S. Uso deprobióticos para disminuir la gravedad de la dermatitisatópica en población pediátrica: revisión sistemática ymetaanálisis. Actas Dermosifiliogr. 2021 oct; 112(10):881–90. doi: 10.1016/j.ad.2021.06.006

  17. Leser T, Baker A. (2024). Molecular mechanisms ofLacticaseibacillus rhamnosus, LGG probiotic function.Microorganisms. 2024 Apr 14, 12(4):794. doi:10.3390/microorganisms12040794

  18. Cau L, Williams MR, Butcher AM, Nakatsuji T,Kavanaugh JS, Cheng JY, et al. Staphylococcusepidermidis protease EcpA can be a deleteriouscomponent of the skin microbiome in atopic dermatitis.J Allergy Clin Immunol. 2021 Mar; 147(3): 955-966.e16.doi: 10.1016/j.jaci.2020.06.024

  19. Sugimoto T, Atobe S, Kado Y, Takahashi A, MotooriM, et al. Gut microbiota associated with the mitigationeffect of synbiotics on adverse events of neoadjuvantchemotherapy in patients with esophageal cancer: Aretrospective exploratory study. J Med Microbiol. 2023Jun; 72(6). doi: 10.1099/jmm.0.001723

  20. Patra VK, Gallais Sérézal I, Wolf P. Potential of skinmicrobiome, pro- and/or pre-biotics to affect localcutaneous responses to UV exposure. Nutrients. 2020Jun 17; 12(6): 1795. doi: 10.3390/nu12061795

  21. Raharja A, Mahil SK, Barker JN. Psoriasis: a briefoverview. Clin Med (Lond). 2021 May; 21(3): 170-173.doi: 10.7861/clinmed.2021-0257

  22. Barquero-Orias D, Muñoz Moreno-Arrones O, Vañó-Galván S. Alopecia y microbioma: ¿futura dianaterapéutica? Actas Dermosifiliogr. 2021 Mar 19; 112(6):495-502. doi: 10.1016/j.ad.2020.12.005

  23. Hui L, Ting H, Yuanying J, Malcolm W, ShiqunZ. Candidiasis: from cutaneous to systemic, newperspectives of potential targets and therapeuticstrategies. Adv Drug Deliv Rev. 2023 Jun; 199: 114960.doi: 10.1016/j.addr.2023.114960

  24. Tsai WH, Fang YT, Huang TY, Chiang YJ, Lin CG, ChangWW. Heat-killed Lacticaseibacillus paracasei GMNL-653 ameliorates human scalp health by regulating scalpmicrobiome. BMC Microbiol. 2023 Apr 29; 23(1): 121.doi: 10.1186/s12866-023-02870-5

  25. Glatthardt T, Lima RD, de Mattos RM, Ferreira RBR.Microbe interactions within the skin microbiome.Antibiotics (Basel). 2024 Jan 4;13(1): 49. doi: 10.3390/antibiotics13010049

  26. Vidal SI, Menta N, Green L. Dermatitis seborreica enniños y adultos: Una revisión narrativa del panoramaactual de tratamientos. Dermatol Ther (Heidelb) 2025Mar; 15: 599–613. doi: 10.1007/s13555-025-01351-z

  27. Zareie E, Mansouri P, Hosseini H, Sadeghpour O, ShirbeigiL, Hejazi S, Emtiazy M. Effect of oral administration ofTriphala, a polyphenol-rich prebiotic, on scalp sebum inpatients with scalp seborrhea a randomized clinical trial.J Dermatolog Treat. 2022 Mar; 33(2): 1011-1016. doi:10.1080/09546634.2020.1800568

  28. Jusuf NK, Putra IB, Sari L. Differences of microbiomesfound in non-inflammatory and inflammatory lesions ofacne vulgaris. Clin Cosmet Investig Dermatol. 2020 Oct22; 13: 773-780. doi: 10.2147/CCID.S272334

  29. Eguren C, Navarro-Blasco A, Corral-Forteza M, Reolid-Pérez A, Setó-Torrent N, García-Navarro A, Prieto-Merino D, et al. A randomized clinical trial to evaluatethe efficacy of an oral probiotic in acne vulgaris. ActaDerm Venereol. 2024 May 15; 104: adv33206. doi:10.2340/actadv.v104.33206

  30. Jung GW, Tse JE, Guiha I, Rao J. Prospective, randomized,open-label trial comparing the safety, efficacy, andtolerability of an acne treatment regimen with and withouta probiotic supplement and minocycline in subjects withmild to moderate acne. J Cutan Med Surg. 2013 Mar-Apr; 17(2): 114-22. doi: 10.2310/7750.2012.12026

  31. Kang BS, Seo JG, Lee GS, Kim JH, Kim SY, HanYW, et al. Antimicrobial activity of enterocins fromEnterococcus faecalis SL-5 against Propionibacteriumacnes, the causative agent in acne vulgaris, and itstherapeutic effect. J Microbiol. 2009 Feb; 47(1): 101-9.doi: 10.1007/s12275-008-0179-y

  32. Kim M-J, Kim K-P, Choi E, Yim J-H, Choi C, YunH-S, Ahn H-Y, Oh J-Y, Cho Y. Effects of Lactobacillusplantarum CJLP55 on clinical improvement, skincondition and urine bacterial extracellular vesicles inpatients with acne vulgaris: A randomized, double-blind,placebo-controlled study. Nutrients. 2021 Apr; 13(4):1368. doi: 10.3390/nu13041368

  33. Ordoñez-Rojas N, Orellana-Cifuentes J, Blacio-ArceE, Jimenez-Soto R, Briones-Morales V. Utilidad deprobióticos y vitaminas en el tratamiento de dermatitisatópica en la población general. Polo Conoc. 2024 Sep;9(9): 654-71. doi:10.23857/pc.v9i9.7954

  34. Climent E, Martinez-Blanch JF, Llobregat L, Ruzafa-Costas B, Carrión-Gutiérrez MN, Ramírez-BoscáA, et al. Changes in gut microbiota correlates withresponse to treatment with probiotics in patients withatopic dermatitis. a post hoc analysis of a clinical trial.Microorganisms. 2021 Apr 15; 9(4): 854. doi: 10.3390/microorganisms9040854

  35. Umborowati MA, Damayanti D, Anggraeni S,Endaryanto A, Surono IS, Effendy I, et al. The role ofprobiotics in the treatment of adult atopic dermatitis: ameta-analysis of randomized controlled trials. J HealthPopul Nutr. 2022 Aug 17; 41(1): 37. doi: 10.1186/s41043-022-00318-6

  36. Feíto-Rodríguez M, Ramírez-Boscà A, Vidal-Asensi S,Fernández-Nieto D, Ros-Cervera G, Alonso-Usero V, etal. Randomized double-blind placebo-controlled clinicaltrial to evaluate the effect of a mixture of probioticstrains on symptom severity and use of corticosteroids inchildren and adolescents with atopic dermatitis. Clin ExpDermatol. 2023 Apr 27;48(5):495-503. doi: 10.1093/ced/llad007

  37. de Andrade PDSMA, Maria E Silva J, Carregaro V,Sacramento LA, Roberti LR, Aragon DC, et al. Efficacyof probiotics in children and adolescents with atopicdermatitis: A randomized, double-blind, placebocontrolledstudy. Front Nutr. 2022 Jan 26; 8: 833666.doi: 10.3389/fnut.2021.833666

  38. Carucci L, Nocerino R, Paparo L, De Filippis F, CoppolaS, Giglio V, et al. Therapeutic effects elicited by theprobiotic Lacticaseibacillus rhamnosus GG in childrenwith atopic dermatitis. The results of the ProPAD trial.Pediatr Allergy Immunol. 2022 Aug;33(8):e13836. doi:10.1111/pai.13836

  39. Yu Y, Dunaway S, Champer J, Kim J, Alikhan A.Changing our microbiome: probiotics in dermatology.Br J Dermatol. 2020 Jan; 182(1):39-46. doi: 10.1111/bjd.18088

  40. Leroy AK, Cortez de Almeida RF, Obadia DL, FrattiniS, Melo DF. Scalp Seborrheic Dermatitis: what we knowso far. Skin Appendage Disord. 2023 Jun; 9(3):160-164.doi: 10.1159/000529854

  41. Galizia G, Belloni Fortina A, Semenzato A. Seborrheicdermatitis: from microbiome and skin barrierInvolvement to emerging approaches in dermocosmetictreatment. Cosmetics. 2024 Nov; 11(6): 208. doi:10.3390/cosmetics11060208

  42. de Jesus GFA, Rossetto MP, Voytena A, Feder B, BorgesH, da Costa Borges G, et al. Clinical evaluation ofparaprobiotic-associated Bifidobacterium lactis CCT7858 anti-dandruff shampoo efficacy: A randomizedplacebo-controlled clinical trial. Int J Cosmet Sci. 2023Oct; 45(5): 572-580. doi: 10.1111/ics.12850

  43. Feng C, Zhang H, Wang P, Zhang L, Liu X, Yan G, et al.Oroxylin A suppress LL-37 generated rosacea-like skininflammation through the modulation of SIRT3-SOD2-NF-κB signaling pathway. Int Immunopharmacol. 2024Mar 10; 129: 111636. doi: 10.1016/j.intimp.2024.111636

  44. Manfredini M, Barbieri M, Milandri M, Longo C.Probiotics and diet in rosacea: current evidence andfuture perspectives. Biomolecules. 2025 Mar 13; 15(3):411. doi: 10.3390/biom15030411

  45. Yu J, Duan Y, Zhang M, Li Q, Cao M, Song W, et al.Effect of combined probiotics and doxycycline therapyon the gut-skin axis in rosacea. mSystems. 2024 Nov19;9(11):e0120124. doi: 10.1128/msystems.01201-24

  46. Morgado-Carrasco D, Gil-Lianes J, Jourdain E, Piquero-Casals J. Oral supplementation and systemic drugs forskin aging: a narrative review. Actas Dermosifiliogr. 2023Feb; 114(2): 114-124. doi: 10.1016/j.ad.2022.09.014

  47. Birnbaum J, Le Moigne A, Dispensa L, BuchnerL. A review of clinical trials conducted with oral,multicomponent dietary supplements for improvingphotoaged skin. J Drugs Dermatol. 2015 Dec; 14(12):1453-61.

  48. Ariztizabal PA, Lopera MM. Psoriasis: una miradaactual a su patogenia y biomarcadores. Dermatol RevMex. 2024; 68(3): 344-57. doi: 10.24245/drm/bmu.v68i3.9777

  49. Groeger D, O’Mahony L, Murphy EF, Bourke JF, DinanTG, Kiely B, et al. Bifidobacterium infantis 35624modulates host inflammatory processes beyond the gut.Gut Microbes. 2013 Jul-Aug; 4(4): 325-39. doi: 10.4161/gmic.25487

  50. Atabati H, Esmaeili S-A, Saburi E, et al. Probiotics withameliorating effects on the severity of skin inflammationin psoriasis: Evidence from experimental and clinicalstudies. J Cell Physiol. 2020; 235: 8925–8937.Doi:10.1002/jcp.29737

  51. Deng Y, Fang Z, Cui S, Zhao J, Zhang H, Chen W, et al.Evaluation of probiotics for inhibiting hyperproliferationand inflammation relevant to psoriasis in vitro. JFunctional Foods, 2021; 81: 104433. doi:10.1016/j.jff.2021.104433

  52. Darias-Domínguez C, Ramírez-Fernández M.Caracterización del fotoenvejecimiento en consultade Dermatología. Rev Med Electrón. 2023 Ago31; 45(4): 604-616. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18242023000400604&lng=es

  53. Buhaș MC, Candrea R, Gavrilaș LI, Miere D, Tătaru A,Boca A, et al. Transforming psoriasis care: probiotics andprebiotics as novel therapeutic approaches. Int J Mol Sci.2023 Jul 7; 24(13): 11225. doi: 10.3390/ijms241311225

  54. Fernández-Ruiz M, Mosqueda-Peña R, Pérez-Ayala A,Blázquez-Gamero D. Congenital cutaneous candidiasisassociated with maternal peripartum candidemia.Rev Iberoam Micol. 2020 Apr-Jun; 37(2): 68-71. doi:10.1016/j.riam.2020.02.002

  55. Bouopda-Tamo SP. Candida infections: clinical features,diagnosis and treatment. Infect Dis Clin Microbiol. 2020Aug 31; 2(2):91–102. doi:10.36519/idcm.2020.0006

  56. Gits‑Muselli M, Hamane S, Benderdouche M.Dermatomicosis. EMC – Tratado de Medicina. 2020;24(3): 1–12. doi:10.1016/S1636-5410(20)44020

  57. Kimoto-Nira H, Aoki R, Sasaki K, Suzuki C, MizumachiK. Oral intake of heat-killed cells of Lactococcus lactisstrain H61 promotes skin health in women. J Nutr Sci.2012 Dec 6; 1: e18. doi: 10.1017/jns.2012.22

  58. Sibbald C. Alopecia areata: An updated review for 2023.J Cutan Med Surg. 2023 May-Jun; 27(3): 241-59. doi:10.1177/12034754231168839




2020     |     www.medigraphic.com